Results 261 to 270 of about 117,210 (347)

Ovarian Aging: Mechanisms, Age‐Related Disorders, and Therapeutic Interventions

open access: yesMedComm, Volume 6, Issue 12, December 2025.
A comprehensive overview of the molecular mechanisms underlying ovarian aging, its association with age‐related diseases, and potential therapeutic interventions. Ovarian aging involves DNA damage, mitochondrial dysfunction, oxidative stress, telomere attrition, and follicular depletion, driving age‐related infertility, menopause, and multiple systemic
Xingyu Liu   +4 more
wiley   +1 more source

Proteomic Biomarkers of Survival in Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Disease. [PDF]

open access: yesAm J Respir Crit Care Med
Alqalyoobi S   +17 more
europepmc   +1 more source

Musculoskeletal Diseases: Mechanisms and Therapeutic Advances

open access: yesMedComm, Volume 6, Issue 12, December 2025.
Musculoskeletal diseases comprise a broad spectrum of inflammatory, degenerative, and neoplastic disorders. Increasing evidence highlights the central role of immune regulation in their pathogenesis, with complex interactions among immune, bone, muscle, and stromal cells.
Xiao Ma   +17 more
wiley   +1 more source

MUC5B Polymorphism and Susceptibility to Idiopathic Pulmonary Fibrosis in Morocco. [PDF]

open access: yesCureus
Senhaji L   +12 more
europepmc   +1 more source

Prognostic significance of HALP score in İdiopathic Pulmonary Fibrosis-related mortality. [PDF]

open access: yesSarcoidosis Vasc Diffuse Lung Dis
Çolak M   +4 more
europepmc   +1 more source

Immunological Similarities and Differences between Post-COVID-19 Lung Sequelae and Idiopathic Pulmonary Fibrosis [PDF]

open access: gold
Sara Gangi   +7 more
openalex   +1 more source

Mechanical Signaling: Molecular Mechanisms, Biological Functions, Diseases, and Therapeutic Targets

open access: yesMedComm, Volume 6, Issue 12, December 2025.
In this review, we summarize cell–ECM interactions and delve into the complex mechanotransduction. We introduce advanced research methods and emerging clinical tools used to study cellular mechanical phenotypes, mechanotransduction, and disease progression. Additionally, we analyze the role of mechanical biomarkers in the development and progression of
Yicen Long   +5 more
wiley   +1 more source

Alternative Splicing: Molecular Mechanisms, Biological Functions, Diseases, and Potential Therapeutic Targets

open access: yesMedComm, Volume 6, Issue 12, December 2025.
Alternative splicing (AS) expands proteomic diversity and functional complexity in eukaryotes, regulated by spliceosomal components, RNA elements, and epigenetic modifications. Dysregulated AS contributes to diseases, including cancer, neurodegenerative disorders, and cardiovascular conditions, among others. Therapeutic interventions, such as antisense
Zhi‐Min Zhu   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy